Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Fierce 15 nominations are now open! We're looking for the best and brightest in biotech.
Ipsen
Biotech
BridgeBio, Ipsen, George Medicines and more—Chutes & Ladders
BridgeBio spins out oncology company. Ipsen names new North America chief. George Medicines taps ex-Ironwood CEO for same role.
Max Bayer
,
Gabrielle Masson
May 3, 2024 8:30am
Ipsen dives into $1.8B Skyhawk pact to fire up RNA modulator R&D
Apr 22, 2024 7:01am
Ipsen posts mixed liver disease data on Intercept, CymaBay rival
Nov 14, 2023 5:55am
Ipsen still out of luck as EC rejects rare disease drug
Jul 20, 2023 6:32am
Ipsen, Genfit report phase 3 rare liver disease success
Jun 30, 2023 6:15am
Ipsen wins FDA AdComm rare disease vote in split decision
Jun 29, 2023 6:00am